SDC1 and neoplasm: Administration of RSL3 barely suppressed tumor growth in the xenograft model, irrespective of the presence of iron (Fig. 1E), but it notably eliminated CD138+ plasma cells in the bone marrow of the intra-bone model (Fig. 1F).